Consensus Methods

Brian C. Smith, PhD, is Founder, CEO, and Chief Technical Officer of Big Sur Scientific. He is the inventor of the BSS series of patented mid-infrared based cannabis analyzers. Dr. Smith has done pioneering research and published numerous peer-reviewed papers on the application of mid-infrared spectroscopy to cannabis analysis, and sits on the editorial board of Cannabis Science and Technology. He has worked as a laboratory director for a cannabis extractor, as an analytical chemist for Waters Associates and PerkinElmer, and as an analytical instrument salesperson. He has more than 30 years of experience in chemical analysis and has written three books on the subject. Dr. Smith earned his PhD on physical chemistry from Dartmouth College. Direct correspondence to: 

Articles

How will the need for increased testing impact extractors?

The FDA is Coming…Will the Cannabis Industry Be Ready? Part II: In-House Testing for Extractors

This article intends to clarify the main goals of GACP and GMP guidelines, identify differences between the two, and also explore why it is important, when operating within the medicinal cannabis sector, that these two guidelines are complied with and their standards achieved.

GACP and GMP in the Medicinal Cannabis Industry—Is There a Clear Difference?

What does FDA oversight mean for cannabis businesses and the industry as a whole?

The FDA is Coming…Will the Cannabis Industry Be Ready? Part I

Highlights of the challenges facing the cannabis extracts industry and discussion about the need for standardized methods and the role of laboratory accreditation.

Cannabis Extracts: The Need for Standardization and Accreditation in Emerging Industries

Patricia Atkins is a Senior Applications Scientist with SPEX CertiPrep and a member of both the AOAC and ASTM committees for cannabis.

Here we examine the history of cannabis in the US, the role the USP played in that field, and the new role the USP is taking with cannabis for medical use.

Everything Old is New Again: Cannabis Returns to USP

What to consider when creating or using certified reference materials.

Certified Reference Material Manufacturing Challenges

George Anastassov, the CEO of AXIM Biotech, recently spoke to us about the current good manufacturing methods (cGMPs) his company has developed, their significance to the market, and plans for the future.